KMT2A and leukemia: Chen et al. demonstrated its role in regulating chromatin status in histone-lysine N-methyltransferase 2A (KMT2A) mutated leukemias in which SIRT1, acting as a disruptor of telomeric silencing 1-like (DOT1L) antagonist, can induce gene silencing [55].